Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Cuk, Katarina ^a,b   Zucknick, Manuela ^a   Madhavan, Dharanija ^a,b   Schott, Sarah ^b   Golatta, Michael ^b   Heil, Jörg ^b   Marmé, Frederik ^a,b   Turchinovich, Andrey ^a,b   Sinn, Peter ^b   Sohn, Christof ^b   Junkermann, Hans ^b   Schneeweiss, Andreas ^a,b   Burwinkel, Barbara ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MICRORNA; MICRORNA 127 3P; MICRORNA 148B; MICRORNA 376A; MICRORNA 376C; MICRORNA 409 3P; MICRORNA 652; MICRORNA 801; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; MIRN127 MICRORNA, HUMAN; MIRN148 MICRORNA, HUMAN; MIRN376 MICRORNA, HUMAN; MIRN652 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CHROMOSOME 14Q; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; EARLY DIAGNOSIS; FEMALE; GENE FUNCTION; GENETIC ANALYSIS; GENETIC MARKER; GENETIC REGULATION; GENETIC SCREENING; HUMAN; HUMAN CELL; LIFESTYLE; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE PROCEDURE; PROTEIN BLOOD LEVEL; TUMOR VOLUME; BLOOD; BREAST NEOPLASMS; CHROMOSOME 14; DIAGNOSTIC USE; GENETIC ASSOCIATION; GENETICS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 14; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84885978715     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076729     Document Type: Article

References (48)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Howlader N NA, Krapcho M, Neyman N, Aminou R, Waldron W, et al. (2011) SEER Cancer Statistics Review, 1975-2008. National Cancer Institute. Bethesda, MD: http://seer.cancer.gov/csr/1975_2008/. (Accessed on November 7, 2011).
3. Bleyer A, Welch HG, (2012) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367: 1998-2005.
4. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, et al. (2002) Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359: 909-919.
5. Checka CM, Chun JE, Schnabel FR, Lee J, Toth H, (2012) The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol 198: W292-295.
6. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, et al. (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356: 227-236.
7. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, et al. (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25: 5287-5312.
8. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
9. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99: 15524-15529.
10. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, et al. (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141: 672-675.
11. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, et al. (2008) Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 54: 482-490.
12. Cuk K, Zucknick M, Heil J, Madhavan D, Schott S, et al. (2013) Circulating microRNAs in plasma as early detection markers for breast cancer. Int J Cancer 132: 1602-1612.
13. Zhang C, Wang C, Chen X, Yang C, Li K, et al. (2010) Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem 56: 1871-1879.
14. Turchinovich A, Weiz L, Burwinkel B, (2012) Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci 37: 460-465.
15. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
16. Turchinovich A, Weiz L, Langheinz A, Burwinkel B, (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39: 7223-7233.
17. Ihaka R, Gentleman R, (1996) R: a language for data analysis and graphics. J Comput Graph Stat 5: 299-314.
18. DeLong ER, DeLong DM, Clarke-Pearson DL, (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
19. Fawcett T, (2006) An introduction to ROC analysis. Pattern Recogn Lett 27: 861-874.
20. Roth C, Rack B, Muller V, Janni W, Pantel K, et al. (2010) Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 12: R90.
21. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, et al. (2010) A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 5: e13735.
22. Guo LJ, Zhang QY, (2012) Decreased serum miR-181a is a potential new tool for breast cancer screening. Int J Mol Med 30: 680-686.
23. van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, et al. (2012) Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers. Breast Cancer Res 14: R34.
24. Madhavan D, Zucknick M, Wallwiener M, Cuk K, Modugno C, et al. (2012) Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer. Clin Cancer Res 18: 5972-5982.
25. Agueli C, Cammarata G, Salemi D, Dagnino L, Nicoletti R, et al. (2010) 14q32/miRNA clusters loss of heterozygosity in acute lymphoblastic leukemia is associated with up-regulation of BCL11a. Am J Hematol 85: 575-578.
26. Devor EJ, JN DEM, Ramachandran S, Goodheart MJ, Leslie KK, (2012) Global dysregulation of the chromosome 14q32 imprinted region in uterine carcinosarcoma. Exp Ther Med 3: 677-682.
27. Zehavi L, Avraham R, Barzilai A, Bar-Ilan D, Navon R, et al. (2012) Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. Mol Cancer 11: 44.
28. Duan Z, Choy E, Harmon D, Liu X, Susa M, et al. (2011) MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther 10: 1337-1345.
29. Dixon-McIver A, East P, Mein CA, Cazier JB, Molloy G, et al. (2008) Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One 3: e2141.
30. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, et al. (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14: 2348-2360.
31. Mosakhani N, Sarhadi VK, Borze I, Karjalainen-Lindsberg ML, Sundstrom J, et al. (2012) MicroRNA profiling differentiates colorectal cancer according to KRAS status. Genes Chromosomes Cancer 51: 1-9.
32. Lajer CB, Nielsen FC, Friis-Hansen L, Norrild B, Borup R, et al. (2011) Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer 104: 830-840.
33. Leucci E, Onnis A, Cocco M, De Falco G, Imperatore F, et al. (2010) B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression. Int J Cancer 126: 1316-1326.
34. Lin S, Sun JG, Wu JB, Long HX, Zhu CH, et al. (2012) Aberrant microRNAs expression in CD133(+)/CD326(+) human lung adenocarcinoma initiating cells from A549. Mol Cells 33: 277-283.
35. Tsai KW, Wu CW, Hu LY, Li SC, Liao YL, et al. (2011) Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Int J Cancer 129: 2600-2610.
36. Wagner-Ecker M, Schwager C, Wirkner U, Abdollahi A, Huber PE, (2010) MicroRNA expression after ionizing radiation in human endothelial cells. Radiat Oncol 5: 25.
37. Zheng Y, Yin L, Chen H, Yang S, Pan C, et al. (2012) miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma. FEBS Lett 586: 2396-2403.
38. Gao W, Shen H, Liu L, Xu J, Shu Y, (2011) MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol 137: 557-566.
39. Sukata T, Sumida K, Kushida M, Ogata K, Miyata K, et al. (2011) Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages. Toxicol Lett 200: 46-52.
40. Pigati L, Yaddanapudi SC, Iyengar R, Kim DJ, Hearn SA, et al. (2010) Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One 5: e13515.
41. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, et al. (2012) Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 5: 492-497.
42. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D, (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104: 1604-1609.
43. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, et al. (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14: 518-527.
44. Millar EK, Graham PH, McNeil CM, Browne L, O'Toole SA, et al. (2011) Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53. Br J Cancer 105: 272-280.
45. Song WJ, Kim KI, Park SH, Kwon MS, Lee TH, et al. (2012) The Risk Factors Influencing between the Early and Late Recurrence in Systemic Recurrent Breast Cancer. J Breast Cancer 15: 218-223.
46. Valdes EK, Boolbol SK, Cohen JM, Feldman SM, (2005) Malignant transformation of a breast fibroadenoma to cystosarcoma phyllodes: case report and review of the literature. Am Surg 71: 348-353.
47. MacGrogan G, Tavassoli FA, (2003) Central atypical papillomas of the breast: a clinicopathological study of 119 cases. Virchows Arch 443: 609-617.
48. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S, (1993) Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 85: 1644-1656.